75MG Pill — PINK ROUND, 10mm — Ranitidine
| Imprint | 75MG |
|---|---|
| Colour | PINK |
| Shape | ROUND |
| Size | 10 |
| Strength | RANITIDINE HYDROCHLORIDE 75 mg;CELLULOSE, MICROCRYSTALLINE 80 mg;STARCH, CORN 30 mg;POVIDONE K30 10 mg;METHYLPARABEN 3 mg;MAGNESIUM STEARATE 20 mg;TALC 30 mg;SODIUM STARCH GLYCOLATE TYPE A POTATO 40 mg;SILICON DIOXIDE 1 mg |
| Dosage form | Tablet |
| Manufacturer | A P J Laboratories Limited |
| NDC | 46084-031 |
| Schedule | — |
| Availability | — |
| Ingredients | RANITIDINE HYDROCHLORIDE[RANITIDINE];CELLULOSE, MICROCRYSTALLINE[];STARCH, CORN[];POVIDONE K30[];METHYLPARABEN[];MAGNESIUM STEARATE[];TALC[];SODIUM STARCH GLYCOLATE TYPE A POTATO[];SILICON DIOXIDE[] |
What does this imprint mean?
The imprint "75MG" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Ranitidine
Uses and warnings
No boxed warning in the originally approved label. "Ranitidine is contraindicated for patients known to have hypersensitivity to the drug or any of the ingredients," with caution advised in patients with a history of acute porphyria and in renal or hepatic impairment. IMPORTANT UPDATE: in April 2020 the FDA requested that all manufacturers withdraw ranitidine (prescription and over-the-counter) from the US market after testing found unacceptable levels of the probable human carcinogen NDMA (N-nitrosodimethylamine) in some products, levels that can increase with time and storage at higher temperatures; all ranitidine products were subsequently recalled or discontinued, and this is no longer an active, marketed FDA-approved label.
Ranitidine tablets were historically indicated for short-term treatment of active duodenal ulcer, maintenance therapy for duodenal ulcer at reduced dosage, treatment of active benign gastric ulcer, pathological hypersecretory conditions such as "Zollinger-Ellison syndrome," treatment and maintenance of erosive esophagitis, and treatment of gastroesophageal reflux disease (GERD) symptoms, noting that "symptomatic relief commonly occurs within 24 hours."
How to identify this pill
- • Check the imprint matches exactly: "75MG".
- • Confirm the colour (PINK) and shape (ROUND).
- • Compare the size (10) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
X 53
PINK ROUND · Montelukast
b 978
PINK ROUND · Estradiol
R20
PINK ROUND · Rosuvastatin
X C
PINK ROUND · Rosuvastatin
NP 12
PINK ROUND · Oxycodone
E 173
PINK ROUND · Lisinopril
Z3
PINK ROUND · Estradiol
W 972
PINK ROUND · Famotidine
SZ 228
PINK ROUND · Zolpidem
H R4
PINK ROUND · Rosuvastatin
V259
PINK ROUND · Folic Acid
M L21
PINK ROUND · Lovastatin
Other pills of Ranitidine
ZANTAC 150
ORANGE FREEFORM · Ranitidine
GG 614
BROWN CAPSULE · Ranitidine
V 02
ORANGE ROUND · Ranitidine
APO RAN
BLUE ROUND · Ranitidine
V 42
YELLOW CAPSULE · Ranitidine
W741
ORANGE HEXAGON (6 SIDED) · Ranitidine
9R
WHITE OVAL · Ranitidine
Z 150
BLUE PENTAGON (5 SIDED) · Ranitidine
V 30
PINK PENTAGON (5 SIDED) · Ranitidine
002 novitium300mg
BROWN CAPSULE · Ranitidine
CD 130
BROWN CAPSULE · Ranitidine
BLUE ROUND · Ranitidine
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file cbc1050f-9b82-4e4c-aa84-78ba062e75b0.xml